1. Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res 2012; 2: 6.
2.
Rugtveit J, Nilsen EM, Bakka A, et al. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112: 1493-505.
3.
Schottlender N, Gottfried I, Ashery U. Hyperbaric oxygen treatment: effects on mitochondrial function and oxidative stress. Biomolecules 2021; 11: 1827.
4.
De Wolde SD, Hulskes RH, Weenink RP, et al. The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis. Biomolecules 2021; 11: 1210.
5.
Pagoldh M, Hultgren E, Arnell P, Eriksson A. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scand J Gastroenterol 2013; 48: 1033-40.
6.
Donoghue DP, Hyland JM. Perianal Crohn’s disease. Eur J Gastroenterol Hepatol 1997; 9: 235-6.
7.
Colombel JF, Mathieu D, Bouault JM, et al. Hyperbaric oxygenation in severe perineal Crohn’s disease. Dis Colon Rectum 1995; 38: 609-14.
8.
Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for complex perianal fistula in Crohn’s disease. World J Gastroenterol 2009; 15: 4263-42.
9.
Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 2004; 60: 505-12.
10.
Torres J, Bonovas S, Doherty G, et al. ECCO guideline sumarized. J Crohn’s Colitis 2020; 14: 4-22.
11.
Pikarsky AJ, Gervaz P, Wexner SD. Perianal Crohn disease a new scoring system to evaluate and predict outcome of surgical intervention. Arch Surg 2002; 137: 774-8.
12.
Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 2002; 122: 512-30.
13.
Armuzzi A, Pugliese D. Hyperbaric oxygen therapy: more hope than hype for future treatment of perianal fistulizing Crohn’s disease? United European Gastroenterol J 2022; 10: 143-4.
14.
Wang X, Shen B. Advances in perianal disease associated with Crohn’s disease-evolving approaches. Gastrointest Endosc Clin N Am 2019; 29: 515-30.
15.
Lansdorp CA, Buskens CJ, Gecse KB, et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease: results of the HOT-TOPIC trial after 1-year follow-up. United European Gastroenterol J 2022; 10: 160-8.
16.
McCurdy J, Siw KCK, Kandel R, et al. The effectiveness and safety of hyperbaric oxygen therapy in various phenotypes of inflammatory bowel disease: systematic review with meta-analysis. Inflamm Bowel Dis 2022; 28: 611-21.
17.
Singh AK, Jha DK, Jena A, et al. Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021; 33 (Suppl 1): e564-73.
18.
Kaur H, Kochhar GS, Dulai PS. Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease. Curr Opin Gastroenterol 2023; 39: 263-7.
19.
Wu X, Liang TY, Wang Z, Chen G. The role of hyperbaric oxygen therapy in inflammatory bowel disease: a narrative review. Med Gas Res 2021; 11: 66-71.
20.
You JH, Jiang JL, He WB, et al. Addition of hyperbaric oxygen therapy versus usual care alone for inflammatory bowel disease: a systematic review and meta-analysis. Heliyon 2022; 8: e11007.
21.
Kim PH, Park SH, Jin K, et al. Supplementary anal imaging by magnetic resonance enterography in patients with Crohn’s disease not suspected of having perianal fistulas. Clin Gastroenterol Hepatol 2020; 18: 415-23.
22.
Panés J, Rimola J. Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol 2017; 14: 652-64.
23.
Agrawal G, Borody T, Turner R, et al. Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn’s disease. Future Sci OA 2015; 1: FSO77.
24.
Aguilera-Castro L, Ferre-Aracil C, Garcia-Garcia-de-Paredes A, et al. Management of complex perianal Crohn’s disease. Ann Gastroenterol 2017; 30: 33-44.
25.
McCurdy J, Siw KCK, Kandel R, et al. The effectiveness and safety of hyperbaric oxygen therapy in various phenotypes of inflammatory bowel disease: systematic review with meta-analysis. Inflamm Bowel Dis 2022; 28: 611-21.
26.
Gergely M, Prado E, Deepak P. Management of refractory inflammatory bowel disease. Curr Opin Gastroenterol 2022; 38: 347-57.